Mizuho Securities analyst Richard Anderson reiterated a Buy rating on HCP Inc (NYSE: HCP) yesterday and set a price target of $29. The company’s shares closed on Friday at $25.98.
According to TipRanks.com, Anderson is a 4-star analyst with an average return of 5.6% and a 67.6% success rate. Anderson covers the Financial sector, focusing on stocks such as Apartment Investment & Management, Hudson Pacific Properties, and National Health Investors.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for HCP Inc with a $27.50 average price target, representing a 5.9% upside. In a report issued on August 6, Stifel Nicolaus also maintained a Buy rating on the stock with a $28 price target.
.
See today’s analyst top recommended stocks >>
HCP Inc’s market cap is currently $12.21B and has a P/E ratio of 216.50. The company has a Price to Book ratio of 2.37.
Based on the recent corporate insider activity of 34 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of HCP in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
HCP, Inc. is a real estate investment trust which invests primarily in real estate serving the healthcare industry in the United States. It acquires, develops, leases, sells, and manages healthcare real estate and provides mortgage and other financing to healthcare providers.
